D-MELD risk capping improves post-transplant and overall mortality under markov microsimulation.

Area of Science:

• Hepatology
• Transplantation Medicine
• Biostatistics

Background:

• Liver transplantation is a life-saving procedure for end-stage liver disease.
• Current allocation systems aim to maximize survival but face challenges in optimizing outcomes for all patient groups.
• The Model for End-Stage Liver Disease (MELD) score is a key metric for organ allocation.

Purpose of the Study:

• To evaluate the impact of a calculated D-MELD (Donor-Model for End-Stage Liver Disease) risk cap combined with Rule 14 on liver transplant and overall survival.
• To determine if these modifications can improve outcomes for patients listed for liver transplantation.

Main Methods:

• Utilized Markov simulation based on United Network for Organ Sharing database data (2002-2004).
• Simulated outcomes with D-MELD risk caps of 1200 or 1600, and with Rule 14 (MELD ≤ 14).
• Assessed the differential impact of these rule changes on survival probabilities.

Main Results:

• The D-MELD risk cap of 1200 improved post-transplant survival.
• Both 1200 and 1600 D-MELD risk caps enhanced overall survival for waitlisted patients.
• Rule 14 further improved survival by redistributing donor livers to higher MELD subgroups, benefiting moderate MELD recipients.

Conclusions:

• A 1200 D-MELD risk cap combined with Rule 14 offers the greatest benefit for liver transplantation.
• This strategy optimizes outcomes by prioritizing moderate MELD score recipients while ensuring high-quality organs for those with higher MELD scores.
• The findings suggest a refined approach to organ allocation can improve patient survival post-transplant.